CoRAP 2024-2026: A Critical Step Towards Safer Chemical Use in the EU

Dr Steven Brennan
Dr Steven Brennan
3 min readAI-drafted, expert reviewed
Documents on an office desk

The European Chemicals Agency (ECHA) has released its latest update to the Community Rolling Action Plan (CoRAP) for the years 2024 through 2026. This strategic plan identifies 28 chemicals suspected of posing significant risks to human health and the environment, earmarked for thorough evaluation by the competent authorities of 11 Member States. This initiative is a part of the REACH Regulation's ongoing efforts to safeguard public and ecological well-being by scrutinizing substances of concern.

What's New in CoRAP 2024-2026?

The newly updated CoRAP list incorporates 11 substances that have never been evaluated under this scheme before, alongside 17 chemicals carried over from the previous 2023-2025 update. For a notable 11 of these recurring substances, their assessment has been rescheduled, pending the acquisition of further information required under the REACH dossier evaluation procedures.

This year's update showcases a strategic distribution, with 10 substances set for evaluation in 2024, 13 in 2025, and the remaining 5 in 2026. However, stakeholders should note that amendments may be made to the listings for 2025 and 2026 in next year's CoRAP update, reflecting the dynamic and responsive nature of this regulatory framework.

One substance has been removed from the latest CoRAP due to its current low priority for substance evaluation, with a compliance check deemed necessary before any further action. This decision underscores the rigorous and flexible approach taken by ECHA and Member State authorities in prioritizing public health and environmental safety.

The CoRAP Process: Collaboration and Criteria

The development of the CoRAP update is a collaborative effort involving close consultation with Member States, based on established criteria for selecting substances for evaluation. The draft CoRAP, shared with Member States and the Member State Committee (MSC) in late 2023, received official approval in February 2024, leading to its publication this March.

The selection criteria for substances hinge on several factors, including potential risks to human health (particularly sensitive populations), environmental impact, and the extent of public and professional exposure. These criteria ensure a targeted and effective approach to chemical safety and regulatory oversight.

Overview of the Substances and Hazards

Given the detailed and varied information provided about the substances listed for evaluation in the CoRAP update for 2024-2026, here's a concise table summarizing the available uses of these substances based on the initial grounds for concern and other provided details:

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
Substance NameEC/List NumberCAS NumberUses and Concerns
Tetradecamethylcyclohexasiloxane203-499-5107-52-8Suspected PBT/vPvB, consumer use, wide dispersive use
4,4'-Isopropylidenebis[2-allylphenol]217-121-11745-89-7Suspected R, potential endocrine disruptor, worker and environmental exposure
4,4'-Isopropylidenedi2,6-xylol227-033-55613-46-7Similar to above
2,2'-[(1-Methylethylidene)bis(4,1-phenyleneoxy)]bisethyl diacetate242-895-219224-29-4Similar to above
(1-Methylethylidene)bis(4,1-phenyleneoxy-3,1-propanediyl) bismethacrylate248-607-127689-12-9Similar to above
Tetrasodium N,N-bis(carboxylatomethyl)-L-glutamate257-573-751981-21-6Suspected C, consumer and worker exposure, high tonnage
2,4,6-Tribromophenol204-278-6118-79-6Suspected R, potential endocrine disruptor, worker and environmental exposure
4-(1-Methyl-1-phenylethyl)-N-[4-(1-methyl-1-phenylethyl)phenyl] aniline233-215-510081-67-1Suspected PBT/vPvB, consumer use, sensitive populations exposure
Dioctyltin oxide212-791-1870-08-6Potential endocrine disruptor, wide dispersive use, high RCR
Reaction product of Graphite, acid-treated and potassium permanganate947-768-1n.a.Suspected M, worker exposure, wide dispersive use
Oligomerisation products of beta-pinene701-246-8n.a.Suspected PBT/vPvB, consumer use, wide dispersive use
Oligomerisation products of alpha-pinene and beta-pinene701-463-8n.a.Similar to above
1,3-Diisopropylbenzene202-773-199-62-7Suspected R, suspected PBT/vPvB, worker exposure
1,4-Diisopropylbenzene202-826-9100-18-5Similar to above
Bis(2,6-diisopropylphenyl) carbodiimide218-487-52162-74-5Suspected PBT, wide dispersive use, worker exposure
A mixture of: triphenylthiophosphate and tertiary butylated phenyl derivatives421-820-9192268-65-8Suspected PBT/vPvB
Benzaldehyde202-860-4100-52-7Suspected M, wide dispersive use, consumer use
Acrylic acid, monoester with propane-1,2-diol247-118-025584-83-2Suspected C, M, sensitiser, high RCR
Octene, hydroformylation products, low-boiling273-110-168938-03-4Suspected PBT/vPvB, high tonnage
Diethyl Ether200-467-260-29-7Suspected C, M, R, high tonnage
4-(4-Isopropoxyphenylsulfonyl)phenol405-520-595235-30-6Potential endocrine disruptor
Sodium hydroxymethanesulphinate205-739-4149-44-0Suspected C, M, R, high tonnage

Encouraging Industry Engagement

ECHA places a strong emphasis on the active participation of registrants throughout the evaluation process. The agency has provided detailed contact information for the competent authorities responsible for each substance, facilitating open dialogue and cooperation between industry stakeholders and regulatory bodies. This collaborative spirit is particularly urged for the substances slated for evaluation in 2024, emphasizing the shared responsibility in addressing chemical risks.

Access the original source

Foresight continuously tracks 1000s of sources and maps updates to your portfolio:

  • Get alerted when changes affect your products or operations
  • Access source documents with full citations
  • Collaborate with your team on alerts and decisions

Related Articles

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly and get the latest insights on regulatory changes affecting chemical compliance.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX